Stocks
Amylyx Pharmaceuticals (AMLX) FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -75.2 | -182.4 | 10.7 | -167.8 | -123.5 | -120.5 | ||
| Changes by years, y/y, % | +104% | +143% | -106% | -1 671% | -26% | +27.4% | |||
Amylyx Pharmaceuticals. FCF, bln rub
Amylyx Pharmaceuticals. FCF, changes, %
Amylyx Pharmaceuticals. FCF, sum by quarters, bln rub
Amylyx Pharmaceuticals (AMLX) FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| FCF, bln rub | ? | -39.8 | -25.3 | -30.4 | -28.0 | -36.9 | -120.5 | |
| Changes by years, y/y, % | +7 065% | -62% | -27% | -53% | -7% | |||
| Changes by quarters, q/q, % | -33% | -37% | +20% | -8% | +32% | |||
